P&T committee meetings
Proceedings checked September 21, 2026Meeting dates checked November 7, 2026In development
Each date links to the passage on the program's page that states it. (agenda) opens the posted agenda; (tentative) marks a date the program calls tentative.
Upcoming meetings
November 2026
- November 19, 2026 (opens in a new tab)Connecticut: Department of Social Services
- November 19, 2026 (opens in a new tab) (agenda for November 19, 2026 (opens in a new tab))Iowa Department of Health and Human Services, Iowa Medicaid
- November 20, 2026 (opens in a new tab)Alaska Department of Health, Division of Health Care Services
- November 20, 2026 (opens in a new tab) (agenda for November 20, 2026 (opens in a new tab))Indiana: Family and Social Services Administration, Office of Medicaid Policy and Planning
December 2026
- December 1, 2026 (opens in a new tab) (agenda for December 1, 2026 (opens in a new tab))Rhode Island: Executive Office of Health and Human Services
- December 2, 2026 (opens in a new tab) (agenda for December 2, 2026 (opens in a new tab))Montana: Department of Public Health and Human Services
- December 2, 2026 (opens in a new tab) (agenda for December 2, 2026 (opens in a new tab))North Dakota: Department of Health and Human Services, through Acentra Health
- December 3, 2026 (opens in a new tab) (agenda for December 3, 2026 (opens in a new tab))Oregon Health Authority, through the Oregon State University Drug Use Research and Management program
- December 8, 2026 (opens in a new tab)Department of Health and Human Services, MaineCare
- December 9, 2026 (opens in a new tab)Massachusetts: MassHealth
- December 9, 2026 (opens in a new tab)Oklahoma Health Care Authority
- December 10, 2026 (opens in a new tab)Nevada: Division of Health Care Financing and Policy
- December 10, 2026 (opens in a new tab)Department of Vermont Health Access
- December 11, 2026 (opens in a new tab) (agenda for December 11, 2026 (opens in a new tab))Florida: Agency for Health Care Administration
- December 11, 2026 (opens in a new tab)Department of Social Services, South Dakota Medicaid
January 2027
- January 2027 (opens in a new tab) (tentative)New Mexico: Health Care Authority
- January 15, 2027 (opens in a new tab)Alaska Department of Health, Division of Health Care Services
- January 20, 2027 (opens in a new tab)Arkansas Department of Human Services, through Prime Therapeutics
- January 22, 2027 (opens in a new tab)Texas: Health and Human Services Commission
- January 26, 2027 (opens in a new tab) (agenda for January 26, 2027 (opens in a new tab))Arizona Health Care Cost Containment System
February 2027
- February 4, 2027 (opens in a new tab)Oregon Health Authority, through the Oregon State University Drug Use Research and Management program
- February 11, 2027 (opens in a new tab)Department of Vermont Health Access
- February 23, 2027 (opens in a new tab)California: Department of Health Care Services, Medi-Cal Rx
March 2027
- March 5, 2027 (opens in a new tab)Department of Social Services, South Dakota Medicaid
- March 11, 2027 (opens in a new tab)Nevada: Division of Health Care Financing and Policy
- March 17, 2027 (opens in a new tab) (tentative)Georgia: Department of Community Health
April 2027
- April 2027 (opens in a new tab) (tentative)New Mexico: Health Care Authority
- April 1, 2027 (opens in a new tab)Oregon Health Authority, through the Oregon State University Drug Use Research and Management program
- April 8, 2027 (opens in a new tab)Department of Vermont Health Access
- April 15, 2027 (opens in a new tab)Iowa Department of Health and Human Services, Iowa Medicaid
- April 16, 2027 (opens in a new tab)Alaska Department of Health, Division of Health Care Services
- April 21, 2027 (opens in a new tab)Arkansas Department of Human Services, through Prime Therapeutics
May 2027
- May 18, 2027 (opens in a new tab) (tentative)Arizona Health Care Cost Containment System
- May 18, 2027 (opens in a new tab)California: Department of Health Care Services, Medi-Cal Rx
June 2027
- June 3, 2027 (opens in a new tab)Oregon Health Authority, through the Oregon State University Drug Use Research and Management program
- June 10, 2027 (opens in a new tab)Department of Vermont Health Access
- June 16, 2027 (opens in a new tab) (tentative)Georgia: Department of Community Health
- June 17, 2027 (opens in a new tab)Nevada: Division of Health Care Financing and Policy
July 2027
- July 2027 (opens in a new tab) (tentative)New Mexico: Health Care Authority
- July 21, 2027 (opens in a new tab)Arkansas Department of Human Services, through Prime Therapeutics
August 2027
- August 5, 2027 (opens in a new tab)Oregon Health Authority, through the Oregon State University Drug Use Research and Management program
- August 19, 2027 (opens in a new tab)Iowa Department of Health and Human Services, Iowa Medicaid
September 2027
- September 9, 2027 (opens in a new tab)Department of Vermont Health Access
- September 14, 2027 (opens in a new tab)California: Department of Health Care Services, Medi-Cal Rx
- September 15, 2027 (opens in a new tab) (tentative)Georgia: Department of Community Health
- September 16, 2027 (opens in a new tab)Nevada: Division of Health Care Financing and Policy
October 2027
- October 2027 (opens in a new tab) (tentative)New Mexico: Health Care Authority
- October 7, 2027 (opens in a new tab)Oregon Health Authority, through the Oregon State University Drug Use Research and Management program
- October 19, 2027 (opens in a new tab) (tentative)Arizona Health Care Cost Containment System
- October 20, 2027 (opens in a new tab)Arkansas Department of Human Services, through Prime Therapeutics
- October 21, 2027 (opens in a new tab)Department of Vermont Health Access
November 2027
- November 16, 2027 (opens in a new tab)California: Department of Health Care Services, Medi-Cal Rx
- November 18, 2027 (opens in a new tab)Iowa Department of Health and Human Services, Iowa Medicaid
Later dates are listed in each program's row.
Evidence and decisions published 14 of 52
Programs below post clinical reviews and meeting outcomes.
Alabama Medicaid Agency
Pharmacy and Therapeutics Committee Meetings (opens in a new tab)
Meeting announcements, agendas, minutes, and a clinical packet for each quarterly meeting, archived by year from 2020 to 2026.
No future meeting date posted.
Arizona Health Care Cost Containment System
Pharmacy and Therapeutics Committee (opens in a new tab)
Agendas, minutes, a clinical presentation and recommendation slides for every meeting from 2022 to 2026, with written public testimony posted verbatim. The link offered for the October 2025 minutes opens the January 2026 agenda.
Upcoming meetings, as posted on November 7, 2026: January 26, 2027 (opens in a new tab) (agenda for January 26, 2027 (opens in a new tab)); May 18, 2027 (opens in a new tab) (tentative); October 19, 2027 (opens in a new tab) (tentative); January 18, 2028 (opens in a new tab) (tentative); May 23, 2028 (opens in a new tab) (tentative); October 17, 2028 (opens in a new tab) (tentative); January 17, 2029 (opens in a new tab) (tentative).
Iowa Department of Health and Human Services, Iowa Medicaid
Pharmaceutical and Therapeutics Committee Info (opens in a new tab)
Per-drug monographs on the archived meeting pages from 2024 to 2026, with minutes from 2023 to 2026, agendas, the committee roster and the conflict of interest policy. The monograph pages sit apart from the minutes.
Upcoming meetings, as posted on November 7, 2026: November 19, 2026 (opens in a new tab) (agenda for November 19, 2026 (opens in a new tab)); April 15, 2027 (opens in a new tab); August 19, 2027 (opens in a new tab); November 18, 2027 (opens in a new tab).
Stated schedule: The Committee meets three times a year, the third Thursdays of April, August and November (opens in a new tab)
Kentucky: Cabinet for Health and Family Services, Department for Medicaid Services
Pharmacy and Therapeutics Advisory Committee (opens in a new tab)
A document for each meeting from 2023 to 2026 reviewing the drugs before the committee and setting out its options, the committee’s recommendations with its votes, and the Commissioner’s final decisions as a separate record. Earlier meetings are released only in answer to an open records request.
No future meeting date posted.
Missouri: Department of Social Services, MO HealthNet
Drug Prior Authorization Committee meetings (opens in a new tab)
Roughly forty per-drug and per-class proposals for each quarterly meeting from 2024 to 2026, each giving the epidemiology, the utilization and spending, and the grounds on which the issue was selected. Earlier meetings are held by the Missouri State Archives.
No future meeting date posted.
New Jersey: Department of Human Services, Division of Medical Assistance and Health Services
Drug Utilization Review Board (opens in a new tab)
The document packet the board votes on, a meeting summary, and a verbatim transcript of the discussion, for every quarterly meeting from 2006 to 2026.
No future meeting date posted.
New York: Department of Health
Medicaid Drug Utilization Review Program (opens in a new tab)
A therapeutic class review packet, a written meeting summary and a webcast transcript for each meeting from 2021 to 2026, with annual drug utilization review reports from 2020. Earlier meetings are in a separate historic archive.
No future meeting date posted.
North Dakota: Department of Health and Human Services, through Acentra Health
North Dakota Medicaid DUR Board (opens in a new tab)
An agenda, minutes and a handout for every quarterly meeting from 2020 to 2026, the handout carrying utilization data and clinical treatment overviews with numbered references.
Upcoming meetings, as posted on November 7, 2026: December 2, 2026 (opens in a new tab) (agenda for December 2, 2026 (opens in a new tab)).
Oklahoma Health Care Authority
DUR Board meeting agendas (opens in a new tab)
A board packet for every monthly meeting from 2004 to 2026, carrying market news, product summaries and College of Pharmacy recommendations per class. A meeting’s minutes arrive inside the following month’s packet.
Upcoming meetings, as posted on November 7, 2026: December 9, 2026 (opens in a new tab).
Oregon Health Authority, through the Oregon State University Drug Use Research and Management program
Meetings and Agenda (opens in a new tab)
A complete evidence packet, written testimony, signed recommendations and minutes as four separate documents for every meeting from 2011 to 2026.
Upcoming meetings, as posted on November 7, 2026: December 3, 2026 (opens in a new tab) (agenda for December 3, 2026 (opens in a new tab)); February 4, 2027 (opens in a new tab); April 1, 2027 (opens in a new tab); June 3, 2027 (opens in a new tab); August 5, 2027 (opens in a new tab); October 7, 2027 (opens in a new tab); December 2, 2027 (opens in a new tab).
Stated schedule: Meetings are generally held on the first Thursday of the month from 1 p.m. to 5 p.m. (opens in a new tab)
Department of Social Services, South Dakota Medicaid
Pharmacy and Therapeutics Committee, Boards and Commissions (opens in a new tab)
A board packet for every meeting from 2015 to 2026 carrying the written drug reviews, utilization by therapeutic class and prior authorization updates, with agendas and minutes.
Upcoming meetings, as posted on November 7, 2026: December 11, 2026 (opens in a new tab); March 5, 2027 (opens in a new tab).
Tennessee: Division of TennCare, through Optum Rx
TennCare Pharmacy Advisory Committee (opens in a new tab)
A review packet for each meeting carrying new drug reviews with named pivotal trials and standard and abbreviated class reviews, with minutes and agendas. Documents opened for 2025 and 2026; the index does not show how far back the record runs.
No future meeting date posted.
Texas: Health and Human Services Commission
Drug Utilization Review Board documents (opens in a new tab)
A therapeutic class review written by the program’s contractor and attached to each agenda item, with minutes recording roll-call votes on prior authorization criteria, from July 2025 onward. Earlier meetings are released only in answer to a records request.
Upcoming meetings, as posted on November 7, 2026: January 22, 2027 (opens in a new tab).
Stated schedule: The Texas Drug Utilization Review (DUR) Board meets quarterly in Austin (opens in a new tab)
Washington State Health Care Authority
Meetings and materials, Pharmacy and Therapeutics Committee and Drug Utilization Review Board (opens in a new tab)
Quarterly meeting dates, topic agendas, recordings and transcripts, committee motions, drug class reviews, and the stakeholder list that distributes agendas by email, for the current calendar year. A drug class review comes down 30 days after its meeting, by the program’s own statement.
No future meeting date posted.
Decisions published, evidence not published 30 of 52
Programs below post minutes or an equivalent record of what the committee changed, but do not publish clinical reviews.
Arkansas Department of Human Services, through Prime Therapeutics
Arkansas provider documents, DUR Board (opens in a new tab)
Drug Utilization Review Board agendas and minutes from 2019 to 2026, alongside memoranda of approved prior authorization criteria indexed back to 2010.
Upcoming meetings, as posted on November 7, 2026: January 20, 2027 (opens in a new tab); April 21, 2027 (opens in a new tab); July 21, 2027 (opens in a new tab); October 20, 2027 (opens in a new tab).
California: Department of Health Care Services, Medi-Cal Rx
Medi-Cal Rx Drug Utilization Review Board (opens in a new tab)
Agenda packets and minutes for every quarterly meeting from 2022 to 2026, covering utilization review, quality measures and drug utilization alerts.
Upcoming meetings, as posted on November 7, 2026: February 23, 2027 (opens in a new tab); May 18, 2027 (opens in a new tab); September 14, 2027 (opens in a new tab); November 16, 2027 (opens in a new tab).
Colorado: Department of Health Care Policy and Financing
Pharmacy and Therapeutics Committee (opens in a new tab)
Quarterly agendas, signed minutes, and a drug class review announcement giving the classes under review with rebate and testimony deadlines, for meetings from 2025 to 2026.
No future meeting date posted.
Stated schedule: The Committee meets once quarterly in January, April, July, and October. (opens in a new tab)
Connecticut: Department of Social Services
Pharmacy information, Connecticut Medical Assistance Program (opens in a new tab)
Minutes of the twice-yearly meetings from 2004 to 2024, the committee bylaws, and a Department of Social Services document accepting the recommendations class by class.
Upcoming meetings, as posted on November 7, 2026: November 19, 2026 (opens in a new tab).
Department of Defense: Defense Health Agency, Military Health System
DOD Pharmacy & Therapeutics Committee (opens in a new tab)
Quarterly meeting dates, the drug classes under review at each meeting, designated newly approved drugs, utilization management items, meeting minutes, and the uniform formulary request for quote deadlines. Every meeting from 1998 to 2025 is indexed, one year at a time.
No future meeting date posted.
Georgia: Department of Community Health
Drug Utilization Review Board (opens in a new tab)
Per-meeting handouts carrying the prior meeting’s minutes, board recommendations by drug, and a separate document recording the decisions the department adopted, for every meeting from 2024 to 2026.
Upcoming meetings, as posted on November 7, 2026: March 17, 2027 (opens in a new tab) (tentative); June 16, 2027 (opens in a new tab) (tentative); September 15, 2027 (opens in a new tab) (tentative); December 8, 2027 (opens in a new tab) (tentative).
Hawaii: Med-QUEST Division
Med-QUEST Drug Use Review Program (opens in a new tab)
Public meeting notices, agendas and minutes for the Drug Utilization Review Board, covering program administration, prescription monitoring data and board bylaws. Meetings from 2021 and from 2023 to 2026; nothing is posted for 2022.
The dates recorded on November 7, 2026 have passed. The program's page (opens in a new tab) carries any later meetings.
Illinois: Department of Healthcare and Family Services
Committee on Drugs and Therapeutics (opens in a new tab)
Minutes from 2020 to 2026 and agendas from 2021 to 2026 on a dedicated archive page, with a published class review schedule and a public testimony registration form.
No future meeting date posted.
Kansas: Department of Health and Environment
Drug Utilization Review Board (opens in a new tab)
Quarterly agendas and minutes from 2017 to 2026, the minutes structured as topic, discussion and decision with public comment recorded per item.
The dates recorded on November 7, 2026 have passed. The program's page (opens in a new tab) carries any later meetings.
Stated schedule: The Drug Utilization Review Board (DUR) meets quarterly, the third Wednesday in the months of February, May, August, and November (opens in a new tab)
Louisiana Department of Health
Pharmaceutical and Therapeutics Committee (opens in a new tab)
Agendas from 2011 to 2026, the classes scheduled for review, annual preferred drug list reports and prior authorization implementation schedules. Minutes are posted for recent meetings only.
No future meeting date posted.
Department of Health and Human Services, MaineCare
MaineCare Drug Utilization Review Committee (opens in a new tab)
An unbroken minutes series from 2020 to 2025 with agendas from 2021 to 2026, the minutes carrying a drug-by-drug clinical narrative for each new drug.
Upcoming meetings, as posted on November 7, 2026: December 8, 2026 (opens in a new tab).
Massachusetts: MassHealth
Drug Utilization Review Board meeting minutes (opens in a new tab)
Indexed agendas and minutes from December 2010 to September 2026, each posted as a PDF and as plain text. None of the minutes would open on the day this was checked.
Upcoming meetings, as posted on November 7, 2026: December 9, 2026 (opens in a new tab).
Michigan: Department of Health and Human Services, through Prime Therapeutics
Michigan Pharmacy and Therapeutics Committee (opens in a new tab)
An agenda, minutes and a materials packet for every quarterly meeting from 2021 to 2026, the packet carrying new drug descriptions, prior authorization criteria and the full preferred drug list.
No future meeting date posted.
Minnesota: Department of Human Services
Drug Formulary Committee (opens in a new tab)
Minutes from 2020 to 2026 recording each drug, the vote margin and the exact criterion language the committee amended. The packet the committee reads is posted for the meeting ahead and comes down once that meeting has passed.
No future meeting date posted.
Mississippi: Division of Medicaid
Pharmacy and Therapeutics Committee (opens in a new tab)
Agendas and detailed minutes for every meeting from 2004 to 2026, reproducing the resulting preferred and non-preferred tables with changes highlighted.
Meeting dates not collected.
Montana: Department of Public Health and Human Services
Drug Utilization Review Board (opens in a new tab)
Agendas and minutes for the six or seven meetings a year from 2023 to 2026, with earlier meetings on a separate archive page the board page links to.
Upcoming meetings, as posted on November 7, 2026: December 2, 2026 (opens in a new tab) (agenda for December 2, 2026 (opens in a new tab)).
Nebraska: Department of Health and Human Services, through the pharmacy benefit administrator
Pharmacy and Therapeutics Committee (opens in a new tab)
Agendas and minutes for about 36 meetings from 2009 to 2026, the minutes carrying a roll-call vote naming each member and reproducing the adopted drug criteria in full.
No future meeting date posted.
Nevada: Division of Health Care Financing and Policy
Silver State Scripts Board (opens in a new tab)
Agendas, near-verbatim minutes, public comments and manufacturer testimonials for every meeting from 2021 to 2026.
Upcoming meetings, as posted on November 7, 2026: December 10, 2026 (opens in a new tab); March 11, 2027 (opens in a new tab); June 17, 2027 (opens in a new tab); September 16, 2027 (opens in a new tab); December 9, 2027 (opens in a new tab).
New Hampshire: Department of Health and Human Services, through Prime Therapeutics
New Hampshire Medicaid pharmacy (opens in a new tab)
Drug Utilization Review Board agendas from 2014 to 2026 and minutes from 2021 to 2025, with prior authorization criteria sheets and superseded preferred drug lists.
No future meeting date posted.
North Carolina: Department of Health and Human Services, NC Medicaid
Preferred drug list meeting archive (opens in a new tab)
Agenda and minutes for nineteen review panel meetings from 2018 to 2026, with recommendations, speakers and the recorded vote per category.
No future meeting date posted.
Ohio: Department of Medicaid
Pharmacy and Therapeutics Committee (opens in a new tab)
Agendas and minutes for every quarterly meeting from 2012 to 2026, the minutes naming each drug, the department recommendation, the vote and the resulting criteria in full.
No future meeting date posted.
Pennsylvania: Department of Human Services
Pharmacy and Therapeutics Committee (opens in a new tab)
Agendas on the department site and recommendation documents carrying significant points of discussion by drug class, distributed through a mailing list archive covering 2010 and 2012 to 2025. Documents arrive as attachments to an email.
No future meeting date posted.
Rhode Island: Executive Office of Health and Human Services
Pharmacy and Therapeutics Committee (opens in a new tab)
Twenty years of quarterly minutes, from 2006 to 2026, as a per-class table giving compliance, the recommendation, the discussion and the vote, with public testimony logged by speaker. Only the current agenda is kept.
Upcoming meetings, as posted on November 7, 2026: December 1, 2026 (opens in a new tab) (agenda for December 1, 2026 (opens in a new tab)).
South Carolina: Department of Health and Human Services, through the pharmacy benefit administrator
Pharmacy and Therapeutics Committee (opens in a new tab)
Seventy-five sets of minutes, from 2004 to 2026, recording each preferred drug list change, the mover and seconder, and the manufacturers who spoke. The meeting materials table reads that none are available, for every year.
No future meeting date posted.
Department of Health and Human Services, Utah Medicaid
Drug Utilization Review Board (opens in a new tab)
Minutes from 2022 to 2026, listed one year at a time, recording for each topic the information presented, the board’s discussion and the action taken, naming members and their reasoning, with a recording of each meeting.
No future meeting date posted.
Stated schedule: These meetings are held virtually on the second Thursday of every month at 7:15 A.M. (opens in a new tab)
Department of Vermont Health Access
Drug Utilization Review Board (opens in a new tab)
Agendas and minutes for the five to seven meetings a year from 2019 to 2026, the minutes recording each board decision with the adopted prior authorization criteria set out in full.
Upcoming meetings, as posted on November 7, 2026: December 10, 2026 (opens in a new tab); February 11, 2027 (opens in a new tab); April 8, 2027 (opens in a new tab); June 10, 2027 (opens in a new tab); September 9, 2027 (opens in a new tab); October 21, 2027 (opens in a new tab); December 9, 2027 (opens in a new tab).
Virginia: Department of Medical Assistance Services
Virginia Medicaid Pharmacy Services, P&T Committee (opens in a new tab)
Minutes from 2005 to 2026 across a current list and an archive section, with committee bylaws and a document describing the recommendations process. Only the current agenda is kept.
No future meeting date posted.
West Virginia: Bureau for Medical Services
Pharmaceutical and Therapeutics Committee meetings (opens in a new tab)
Agendas, minutes and a changes-only document per meeting recording the resulting preferred drug list edits, with a speaker disclosure form. Meetings listed from 2022 to 2026, though only the 2025 and 2026 documents open.
No future meeting date posted.
Wisconsin: Department of Health Services, ForwardHealth
Prior Authorization Advisory Committee (opens in a new tab)
A recommendations summary for each of the two meetings a year from 2012 to 2026, giving every product’s market share, its current and recommended status, and any change the department or the secretary made to the committee’s recommendation.
No future meeting date posted.
Wyoming Department of Health, through the University of Wyoming
Wyoming Medicaid Drug Utilization Review (opens in a new tab)
Minutes for every quarterly meeting from 2010 to 2026, transcribing manufacturer presentations, the board’s clinical questions and the motion with its conditions, with published comment forms.
The dates recorded on November 7, 2026 have passed. The program's page (opens in a new tab) carries any later meetings.
Schedule only 8 of 52
Programs below post meeting dates and agendas, but do not publish meeting outcomes.
Alaska Department of Health, Division of Health Care Services
Medicaid Pharmacy and Therapeutics Committee (opens in a new tab)
Committee information, a form for manufacturers to submit clinical evidence, and the schedule of drug classes to be reviewed in state fiscal years 2023 to 2027. Documents come down 25 months after they are posted, and the state library archive that receives them stops at 2022.
Upcoming meetings, as posted on November 7, 2026: November 20, 2026 (opens in a new tab); January 15, 2027 (opens in a new tab); April 16, 2027 (opens in a new tab).
Department of Health and Social Services, Delaware Medicaid
Pharmacy Corner document repository (opens in a new tab)
Committee bylaws, member list, meeting logistics, public testimony guidelines and a single current agenda. A new version replaces the old one at the same address.
No future meeting date posted.
District of Columbia: Department of Health Care Finance, through Prime Therapeutics
DC Medicaid preferred drug list and P&T Committee (opens in a new tab)
Meeting notices and agendas for every quarter from 2007 to 2026, naming the classes under review, with speaker testimony guidelines. No minutes are published.
No future meeting date posted.
Florida: Agency for Health Care Administration
Pharmacy meeting notices (opens in a new tab)
The agenda for the next Pharmaceutical and Therapeutics and Drug Utilization Review meeting, with public comment forms and quarterly drug utilization reports from 2022 to 2026. Past agendas are not kept.
Upcoming meetings, as posted on November 7, 2026: December 11, 2026 (opens in a new tab) (agenda for December 11, 2026 (opens in a new tab)).
Idaho: Department of Health and Welfare
Pharmacy and Therapeutics Committee (opens in a new tab)
Committee bylaws, a drug class review schedule, a written submission policy for manufacturers, and an agenda for each meeting on the state public meeting portal. No minutes and no recordings are published.
No future meeting date posted.
Stated schedule: Meetings occur on the first Friday of April, May, October, and November. (opens in a new tab)
Indiana: Family and Social Services Administration, Office of Medicaid Policy and Planning
OMPP meetings and agendas (opens in a new tab)
Monthly Drug Utilization Review Board agendas from 2020 to 2026, with agendas for the mental health quality committee and the vendor’s therapeutics committee. No minutes are published.
Upcoming meetings, as posted on November 7, 2026: November 20, 2026 (opens in a new tab) (agenda for November 20, 2026 (opens in a new tab)).
Maryland Department of Health
Pharmacy and Therapeutics Committee (opens in a new tab)
The next meeting date, a public testimony registration form and an attendance registration link. The index of minutes and every file it lists return a not-found error.
No future meeting date posted.
New Mexico: Health Care Authority
Medicaid pharmacy (opens in a new tab)
The current preferred drug list and a quarterly public meeting notice giving the date, time and location. No agendas, minutes or reviews are posted; the notice gives the agenda out by email from a named member of staff.
Upcoming meetings, as posted on November 7, 2026: January 2027 (opens in a new tab) (tentative); April 2027 (opens in a new tab) (tentative); July 2027 (opens in a new tab) (tentative); October 2027 (opens in a new tab) (tentative).